Have you followed us in the news lately? We have had articles written about the Institute and about the Creighton Model System and NaProTechnology recently featured in the Chicago Tribune, Legatus Magazine, and Columbia Magazine!
Also, the NaPro approach to diagnosing and treating infertility will be the topic of discussion on the upcoming August 10th broadcast of Catholic Answers!
Follow the Pope Paul VI Institute and the Creighton Model System and NaProTechnology in the news at www.popepaulvi.com/inthenews.htm!
This summer, I will be presenting at the 2011 American Academy of FertilityCare Professionals Annual Meeting, which will be held in Duluth, Minnesota from July 20th through the 23rd. I will be speaking on Thursday morning, the 21st of July, on The Fetal Safety of Progesterone in Pregnancy. During my talk, I will be presenting the largest database in the world on the use of progesterone in pregnancy. I will detail fetal anomalies and will then compare the use of progesterone support with non-use. And, I will review the medical literature available on this topic.
I will also be available for two Q&A break-out sessions. The first one on Friday will be for medical professionals and will explore issues about NaProTechnology. The second session on Saturday will be for all attendees and will consider the application of the Creighton Model System and NaProTechnology and will explore practical uses of these in case-related areas.
I hope you can incorporate this meeting in your summer plans. For more information and to register, visit http://www.aafcp.org and click on “Annual Meeting” under the Events tab.
I am going to be speaking at a conference Saturday, September 12, 2009 at the Medical School of Lublin in Poland. At this conference, I am going to detail how Creighton Model FertilityCareTM System, which is a standardized charting record of biomarkers (such as bleeding, mucus discharge, and dry days) related to the menstrual and fertility cycles, is used to assess normal and abnormal gynecologic and reproductive function. It is essential that women keep good gynecologic charting records. Because the Creighton Model System is standardized, objective and prospective, it provides very accurate information. Thus, as one uses this system as a natural means of regulating fertility, one also uses it as a women’s health maintenance system. It can, therefore, indicate with a reasonable degree of likelihood that the possibility of certain gynecologic conditions exists.
Then, this Creighton Model information is used wtih the new health science of NaProTECHNOLOGY, which devotes its medical, surgical and allied health energies and attention to cooperating with the natural procreative mechanisms and functions. When these mechanisms are functioning abnormally, NaProTECHNOLOGY cooperates with the procreative mechanisms in evaluating the condition and producing a form of treatment which corrects the condition, maintains the human ecology and sustains the procreative potential.